{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T13:43:17Z","timestamp":1795095797564,"version":"4.10.2"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T00:00:00Z","timestamp":1597363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T00:00:00Z","timestamp":1597363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The unprecedented coronavirus disease 2019 (COVID-19) epidemic has created a worldwide public health emergency, and there is an urgent need to develop an effective vaccine to control this severe infectious disease. Here, we find that a single vaccination with a replication-defective human type 5 adenovirus encoding the SARS-CoV-2 spike protein (Ad5-nCoV) protect mice completely against mouse-adapted SARS-CoV-2 infection in the upper and lower respiratory tracts. Additionally, a single vaccination with Ad5-nCoV protects ferrets from wild-type SARS-CoV-2 infection in the upper respiratory tract. This study suggests that the mucosal vaccination may provide a desirable protective efficacy and this delivery mode is worth further investigation in human clinical trials.<\/jats:p>","DOI":"10.1038\/s41467-020-17972-1","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T08:22:04Z","timestamp":1597393324000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":245,"title":["A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8083-247X","authenticated-orcid":false,"given":"Shipo","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0748-9641","authenticated-orcid":false,"given":"Gongxun","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9650-112X","authenticated-orcid":false,"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2122-8365","authenticated-orcid":false,"given":"Lei","family":"Shuai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9303-8221","authenticated-orcid":false,"given":"Zhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3112-0243","authenticated-orcid":false,"given":"Zhiyuan","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9041-1919","authenticated-orcid":false,"given":"Busen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4279-5177","authenticated-orcid":false,"given":"Zhenghao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7092-2639","authenticated-orcid":false,"given":"Xiaohong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3467-0646","authenticated-orcid":false,"given":"Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6456-812X","authenticated-orcid":false,"given":"Renqiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5918-3978","authenticated-orcid":false,"given":"Ling","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9427-2645","authenticated-orcid":false,"given":"Jinlong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8055-0018","authenticated-orcid":false,"given":"Qiang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3970-9071","authenticated-orcid":false,"given":"Chong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3412-0425","authenticated-orcid":false,"given":"Yilong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8963-7176","authenticated-orcid":false,"given":"Ting","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5719-7997","authenticated-orcid":false,"given":"Peng","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5034-8131","authenticated-orcid":false,"given":"Jinliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5456-837X","authenticated-orcid":false,"given":"Junjie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2827-2185","authenticated-orcid":false,"given":"Jianmin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0304-4477","authenticated-orcid":false,"given":"Changming","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7366-8974","authenticated-orcid":false,"given":"Lihua","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9242-4211","authenticated-orcid":false,"given":"Zhigao","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5805-2469","authenticated-orcid":false,"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,14]]},"reference":[{"key":"17972_CR1","unstructured":"WHO. Draft landscape of COVID-19 candidate vaccines\u201315 July 2020. https:\/\/www.who.int\/publications\/m\/item\/draft-landscape-of-covid-19-candidate-vaccines. Accessed 19 July 2020."},{"key":"17972_CR2","doi-asserted-by":"publisher","unstructured":"Gao, Q. et al. Rapid development of an inactivated vaccine candidate for SARS-CoV-2. Science, https:\/\/doi.org\/10.1126\/science.abc1932 (2020).","DOI":"10.1126\/science.abc1932"},{"key":"17972_CR3","doi-asserted-by":"publisher","unstructured":"van Doremalen, N. et al. ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques. Nature, https:\/\/doi.org\/10.1038\/s41586-020-2608-y (2020).","DOI":"10.1038\/s41586-020-2608-y"},{"key":"17972_CR4","doi-asserted-by":"publisher","unstructured":"Yu, J. et al. DNA vaccine protection against SARS-CoV-2 in rhesus macaques. Science, https:\/\/doi.org\/10.1126\/science.abc6284 (2020).","DOI":"10.1126\/science.abc6284"},{"key":"17972_CR5","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1016\/S0140-6736(15)60553-0","volume":"385","author":"F Zhu","year":"2015","unstructured":"Zhu, F. et al. Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial. Lancet 385, 2272\u20132279, https:\/\/doi.org\/10.1016\/S0140-6736(15)60553-0 (2015).","journal-title":"Lancet"},{"key":"17972_CR6","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/S0140-6736(16)32617-4","volume":"389","author":"F Zhu","year":"2017","unstructured":"Zhu, F. et al. Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet 389, 621\u2013628, https:\/\/doi.org\/10.1016\/S0140-6736(16)32617-4 (2017).","journal-title":"Lancet"},{"key":"17972_CR7","doi-asserted-by":"publisher","first-page":"e324","DOI":"10.1016\/S2214-109X(16)30367-9","volume":"5","author":"J Li","year":"2017","unstructured":"Li, J. et al. Immunity duration of a recombinant adenovirus type-5 vector-based Ebola vaccine and a homologous prime-boost immunisation in healthy adults in China: final report of a randomised, double-blind, placebo-controlled, phase 1 trial. Lancet Glob. Health 5, e324\u2013e334, https:\/\/doi.org\/10.1016\/S2214-109X(16)30367-9 (2017).","journal-title":"Lancet Glob. Health"},{"key":"17972_CR8","doi-asserted-by":"publisher","unstructured":"Zhu, F. et al. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial. Lancet, https:\/\/doi.org\/10.1016\/S0140-6736(20)31208-3 (2020).","DOI":"10.1016\/S0140-6736(20)31208-3"},{"key":"17972_CR9","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/infdis\/jiy187","volume":"218","author":"Q Guo","year":"2018","unstructured":"Guo, Q. et al. Immunization with a novel human type 5 adenovirus-vectored vaccine expressing the premembrane and envelope proteins of Zika virus provides consistent and sterilizing protection in multiple immunocompetent and immunocompromised animal models. J. Infect. Dis. 218, 365\u2013377, https:\/\/doi.org\/10.1093\/infdis\/jiy187 (2018).","journal-title":"J. Infect. Dis."},{"key":"17972_CR10","doi-asserted-by":"publisher","unstructured":"Shi, J. et al. Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2. Science, https:\/\/doi.org\/10.1126\/science.abb7015 (2020).","DOI":"10.1126\/science.abb7015"},{"key":"17972_CR11","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.chom.2020.03.023","volume":"27","author":"YI Kim","year":"2020","unstructured":"Kim, Y. I. et al. Infection and rapid transmission of SARS-CoV-2 in ferrets. Cell Host Microbe 27, 704\u2013709 e702, https:\/\/doi.org\/10.1016\/j.chom.2020.03.023 (2020).","journal-title":"Cell Host Microbe"},{"key":"17972_CR12","doi-asserted-by":"publisher","unstructured":"Broadbent, A. J. et al. Chapter 59\u2014Respiratory virus vaccines. Mucosal Immunology (Fourth Edition). 1, 1129\u20131170, https:\/\/doi.org\/10.1016\/B978-0-12-415847-4.00059-8 (2015).","DOI":"10.1016\/B978-0-12-415847-4.00059-8"},{"key":"17972_CR13","doi-asserted-by":"publisher","unstructured":"Zens, K. D., Chen, J. K. & Farber, D. L. Vaccine-generated lung tissue-resident memory T cells provide heterosubtypic protection to influenza infection. JCI insight 1, https:\/\/doi.org\/10.1172\/jci.insight.85832 (2016).","DOI":"10.1172\/jci.insight.85832"},{"key":"17972_CR14","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","volume":"372","author":"SP Buchbinder","year":"2008","unstructured":"Buchbinder, S. P. et al. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 372, 1881\u20131893, https:\/\/doi.org\/10.1016\/S0140-6736(08)61591-3 (2008).","journal-title":"Lancet"},{"key":"17972_CR15","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1021\/mp200392g","volume":"9","author":"JH Choi","year":"2012","unstructured":"Choi, J. H. et al. A single sublingual dose of an adenovirus-based vaccine protects against lethal Ebola challenge in mice and guinea pigs. Mol. Pharm. 9, 156\u2013167, https:\/\/doi.org\/10.1021\/mp200392g (2012).","journal-title":"Mol. Pharm."},{"key":"17972_CR16","doi-asserted-by":"publisher","first-page":"e3548","DOI":"10.1371\/journal.pone.0003548","volume":"3","author":"MA Croyle","year":"2008","unstructured":"Croyle, M. A. et al. Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice. PLoS ONE 3, e3548, https:\/\/doi.org\/10.1371\/journal.pone.0003548 (2008).","journal-title":"PLoS ONE"},{"key":"17972_CR17","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S1473-3099(19)30584-5","volume":"20","author":"D Liebowitz","year":"2020","unstructured":"Liebowitz, D. et al. Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study. Lancet Infect. Dis. 20, 435\u2013444, https:\/\/doi.org\/10.1016\/S1473-3099(19)30584-5 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"17972_CR18","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.arbres.2015.11.008","volume":"52","author":"ML Garcia-Garcia","year":"2016","unstructured":"Garcia-Garcia, M. L., Calvo Rey, C. & Del Rosal Rabes, T. Pediatric asthma and viral infection. Archivos Bronconeumol. 52, 269\u2013273, https:\/\/doi.org\/10.1016\/j.arbres.2015.11.008 (2016).","journal-title":"Archivos Bronconeumol."},{"key":"17972_CR19","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.1016\/j.vaccine.2019.05.081","volume":"37","author":"JD Nordin","year":"2019","unstructured":"Nordin, J. D. et al. Safety of guidelines recommending live attenuated influenza vaccine for routine use in children and adolescents with asthma. Vaccine 37, 4055\u20134060, https:\/\/doi.org\/10.1016\/j.vaccine.2019.05.081 (2019).","journal-title":"Vaccine"},{"key":"17972_CR20","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.anai.2017.01.030","volume":"118","author":"J Duffy","year":"2017","unstructured":"Duffy, J. et al. Live attenuated influenza vaccine use and safety in children and adults with asthma. Ann. Allergy Asthma Immunol. 118, 439\u2013444, https:\/\/doi.org\/10.1016\/j.anai.2017.01.030 (2017).","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"17972_CR21","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.jaci.2014.12.1925","volume":"136","author":"PJ Turner","year":"2015","unstructured":"Turner, P. J. et al. Safety of live attenuated influenza vaccine in atopic children with egg allergy. J. Allergy Clin. Immunol. 136, 376\u2013381, https:\/\/doi.org\/10.1016\/j.jaci.2014.12.1925 (2015).","journal-title":"J. Allergy Clin. Immunol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-17972-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-17972-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-17972-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T19:31:51Z","timestamp":1670268711000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-17972-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,14]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["17972"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-17972-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,14]]},"assertion":[{"value":"4 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4081"}}